who makes glp 1 drugs GLP-1 from the Gray Market Market Overview: GLP-1 Agonists and

Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

Additionally, Members of the European Parliament held their inaugural meeting, signalling political commitment and initiating dialogue on obesity priorities across member states

Orlistat (Alli) is the only OTC option